TCRX Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - TScan Therapeutics Inc

Watchlist Manager

Watchlist

Price: 0.203 USD -6.11% Market Closed

Market Cap: $13.3m

T	TScan Therapeutics Inc NASDAQ:TCRX	US
	One 97 Communications Ltd BSE:543396	IN
A	Avantor Inc F:AVG	US
W	Wharf Real Estate Investment Company Ltd OTC:WRFRF	HK
A	Ashington Innovation PLC F:6FW	UK
C	Cummins Inc F:CUM	US

Profitability Summary

TScan Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-1 695%

Negative 3Y Average Operating Margin

-1 778%

Declining Operating Margin

-536% > -1 695%

Negative Net Margin

-1 655%

Negative 3Y Average Net Margin

-1 687%

Declining Net Margin

-521% > -1 655%

Negative Free Cash Flow Margin

-1 666%

Negative 3Y Average Free Cash Flow Margin

-1 575%

Declining Free Cash Flow Margin

-340% > -1 666%

Negative ROE

-96%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-166%

ROIC is Increasing

-185% > -167%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.